Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
31.09B | 30.01B | 28.68B | 25.91B | 22.91B | 28.03B | Gross Profit |
8.67B | 7.72B | 7.47B | 7.05B | 5.89B | 7.42B | EBIT |
4.03B | 3.18B | 3.20B | 3.09B | 2.09B | 3.32B | EBITDA |
5.25B | 5.03B | 4.77B | 4.60B | 3.67B | 3.89B | Net Income Common Stockholders |
2.80B | 2.38B | 2.12B | 1.73B | 1.28B | 1.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.48B | 14.83B | 12.51B | 12.85B | 13.17B | 10.62B | Total Assets |
32.03B | 56.90B | 50.01B | 47.31B | 45.15B | 42.09B | Total Debt |
5.48B | 3.40B | 3.42B | 3.77B | 4.00B | 4.04B | Net Debt |
2.01B | -11.43B | -9.09B | -9.08B | -9.16B | -6.58B | Total Liabilities |
10.00B | 11.74B | 10.20B | 10.48B | 10.18B | 10.06B | Stockholders Equity |
19.52B | 39.22B | 34.33B | 31.81B | 30.47B | 27.97B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.13B | 1.01B | 460.77M | 3.31B | 3.32B | Operating Cash Flow |
0.00 | 4.02B | 1.96B | 1.40B | 4.53B | 4.69B | Investing Cash Flow |
0.00 | -1.35B | -2.13B | -1.27B | -1.70B | -1.50B | Financing Cash Flow |
0.00 | -716.78M | -887.99M | -701.62M | -349.02M | -502.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $846.99B | 9.57 | 13.60% | 3.90% | 7.52% | 19.95% | |
68 Neutral | ¥75.03B | 6.88 | 5.71% | 0.28% | -24.90% | ||
66 Neutral | ¥21.13B | 7.57 | 4.05% | 3.95% | 20.57% | ||
66 Neutral | ¥582.81B | 12.46 | 9.16% | 2.74% | 3.01% | 61.47% | |
66 Neutral | $484.96B | 10.61 | 6.79% | 3.63% | 7.97% | 31.70% | |
49 Neutral | $1.95B | -1.50 | -22.00% | 3.79% | 0.66% | -27.40% | |
47 Neutral | ¥14.80B | 458.08 | ― | -4.30% | ― |